Psilocybin microdosing… scientific [studies]
The new study is one of the first to use placebo controls, the researchers [erroneously, apparently] said.
For their study, researchers recruited 34 people who were planning to start a microdosing regimen. For 1 week, some of the subjects got a half gram of dried mushrooms in a gel cap, and others got a placebo… a double-blind placebo-control crossover study by another group of researchers of 30 respondents followed for 8 weeks identified higher levels of self-reported awe in response to aesthetic experiences among microdosers relative to controls… notably, the subgroup of respondents who reported mental health concerns at the time of baseline assessment exhibited an average reduction in depressive symptoms that resulted in a change from moderate to mild depression following approximately 30 days of microdosing psychedelics. Considering the tremendous health costs and ubiquity of depression, as well as the sizable proportion of patients who do not respond to extant treatments, the potential for another approach to addressing this deadly disorder warrants substantial consideration.
Original Article (KVAL):
Psilocybin microdosing shows no benefit to creativity, cognition, perception in new scientific study & Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
Artwork Fair Use: Natarajan & Raman